This Week in Managed Care—Uninsured Rates Rise Nationwide and Other Health News

Managed Care Cast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included another report that shows uninsured rates are rising; FDA confirms shortages of the EpiPen, but the manufacturer insists the delay will be short; a Senate panel examines the need for transparency in insulin pricing. Read more about the stories in this podcast: No States Reported a Decline in the Uninsured Rate From 2016 to 2017: www.ajmc.com/focus-of-the-week/no-states-reported-a-decline-in-the-uninsured-rate-from-2016-to-2017 FDA Confirms Short-Term Shortages of EpiPen: www.ajmc.com/newsroom/fda-confirms-shortterm-shortages-of-epipen ADA's Cefalu Calls for Transparency Across Supply Chain to Address Insulin Costs: www.ajmc.com/newsroom/adas-cefalu-calls-for-transparency-across-supply-chain-to-address-insulin-costs Daratumumab Approved as Frontline Treatment in Newly Diagnosed Multiple Myeloma: www.ajmc.com/newsroom/daratumumab-approved-as-frontline-treatment-in-newly-diagnosed-multiple-myeloma Single-Payer System Is the Solution for Mental Health Care, Panelists Say: www.ajmc.com/conferences/apa-2018/singlepayer-system-is-the-solution-for-mental-health-care-panelists-say American Psychiatric Association 2018 Annual Meeting: www.ajmc.com/conferences/apa-2018